Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Pharmacology, Biochemistry, and Behavior|January 29, 2026
Protocadherin 10, a member of cadherin superfamily, increases stress-susceptibility in chronic unpredictable stress-treated ratsXin-Mu Li, Ning-Ning Zhang, Xiao-Ling Zhang, et al.
International Journal of Molecular Sciences|February 15, 2022
Rapid, Label-Free Prediction of Antibiotic Resistance in <i>Salmonella typhimurium</i> by Surface-Enhanced Raman SpectroscopyPing Zhang, Xi-Hao Wu, Lan Su, et al.
Neuropharmacology|March 28, 2020
Connexin 43: A novel ginsenoside Rg1-sensitive target in a rat model of depressionCong-Yuan Xia, Zhen-Zhen Wang, Hui-Qin Wang, et al.
International Immunopharmacology|January 22, 2026
Ginsenoside Rg1 ameliorates depression-like behaviors in mice by inhibiting astrocyte pyroptosis via Cx43-dependent restoration of mitophagy fluxZan Xing, Xin-Mu Li, Yuan-Chun Wang, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|February 21, 2019
[A multicenter epidemiological investigation of brain injury in hospitalized preterm infants in Anhui, China]Jian Zhang, Guang-Hui Liu, Yu-Wei Zhao, et al.
Neurochemistry International|June 24, 2021
Hair growth predicts a depression-like phenotype in rats as a mirror of stress traceabilitySi-Yu Ren, Ya-Ni Zhang, Man-Jiang-Cuo Wang, et al.
Pharmacology, Biochemistry, and Behavior|April 4, 2024
Inflammation and Connexin 43 profiles in the prefrontal cortex are relevant to stress susceptibility and resilience in miceHong Jiang, Meng Zhang, Hui-Qin Wang, et al.
Journal of Ethnopharmacology|June 4, 2021
Novel antidepressant mechanism of ginsenoside Rg1: Regulating biosynthesis and degradation of connexin43Hui-Qin Wang, Song-Wei Yang, Yan Gao, et al.
International Journal of General Medicine|December 9, 2021
The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang PopulationRui-Zhi Zeng, Xiao-Dan Lv, Geng-Feng Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2019
Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET ActivationSabrina Baltschukat, Barbara Schacher Engstler, Alan Huang, et al.
Pageof 5